Literature DB >> 6140907

Clinical use of captopril in Takayasu's disease.

E Grossman, B Morag, N Nussinovitch, H Boichis, A Knecht, T Rosenthal.   

Abstract

Three patients with Takayasu's disease (TD), initially observed with hypertension and/or congestive heart failure, were treated with captopril, an orally active inhibitor of converting enzyme. As arteritis in this disease is diffuse and extensive, surgical correction of renovascular hypertension is often delayed or impossible. Our experience enables us to recommend captopril for conservative treatment in TD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140907

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Management of severe hypertension in childhood Takayasu's arteritis.

Authors:  L S Milner; D W Jacobs; P D Thomson; U K Kala; J Franklin; P Beale; S E Levin
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 2.  Cardiovascular drugs in children: angiotensin-converting enzyme inhibitors.

Authors:  A Schneeweiss
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

Review 3.  Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients.

Authors:  A Schneeweiss
Journal:  Pediatr Cardiol       Date:  1990-10       Impact factor: 1.655

Review 4.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Surgical treatment of Takayasu's disease.

Authors:  P Lagneau; J B Michel; P N Vuong
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.